info@allievapharma.com

  • 24/7
    Customer Service
  • ISO 9001
    Certification Company
  • WHO-GMP
    Certified Company
OUR CATALOGUE OUR CATALOGUE

    • Breast Cancer

    Breast Cancer Products

    Discover a wide range of Breast Cancer products under the Oncology category. Allieva Pharma provides high-quality pharmaceutical solutions trusted across India and global markets.

    LAPALIEVA 250 MG Lapatinib Tablets 250 mg by LAPALIEVA 250 MG

    LAPALIEVA 250 MG

    Lapatinib Tablets 250 mg

    LAPALIEVA contains Lapatinib, an oral targeted anticancer agent. It is a tyrosine kinase inhibitor (TKI) that blocks HER2/neu (ErbB2) and EGFR (ErbB1) receptors, inhibiting tumor cell growth and proliferation in HER2-positive breast cancer.

    View Details
    LETROLIEVA 2.5MG Letrozole Tablets IP 2.5 mg by LETROLIEVA 2.5MG

    LETROLIEVA 2.5MG

    Letrozole Tablets IP 2.5 mg

    LETROLIEVA contains Letrozole, a non-steroidal aromatase inhibitor. It works by inhibiting the aromatase enzyme, which decreases estrogen production in postmenopausal women, slowing the growth of estrogen receptor-positive breast cancer cells.

    View Details
    ANALIEVA 1MG Anastrozole Tablets 1 mg by ANALIEVA 1MG

    ANALIEVA 1MG

    Anastrozole Tablets 1 mg

    Analieva contains Anastrozole, an aromatase inhibitor used in hormone-dependent cancers. It works by blocking the enzyme aromatase, which reduces estrogen production in postmenopausal women, slowing the growth of estrogen receptor-positive breast cancer.

    View Details
    PALBOLIEVA 125MG Palbociclib Capsules 125mg by PALBOLIEVA 125MG

    PALBOLIEVA 125MG

    Palbociclib Capsules 125mg

    PALBOLIEVA 125 mg contains Palbociclib, an oral cyclin-dependent kinase (CDK) 4/6 inhibitor. It inhibits CDK4 and CDK6, causing cell-cycle arrest in the G1 phase, thereby slowing the growth of hormone receptor–positive breast cancer cells.

    View Details
    PALBOLIEVA 100MG Palbolieva Capsules 100mg by PALBOLIEVA 100MG

    PALBOLIEVA 100MG

    Palbolieva Capsules 100mg

    PALBOLIEVA 100 mg contains Palbociclib, an oral cyclin-dependent kinase (CDK) 4/6 inhibitor. It works by inhibiting CDK4 and CDK6, leading to cell-cycle arrest in the G1 phase and suppression of cancer cell proliferation, particularly in hormone receptor–positive breast cancer.

    View Details
    FALSOLIEVA 250 MG Fulvestrant Injection 250 MG by FALSOLIEVA 250 MG

    FALSOLIEVA 250 MG

    Fulvestrant Injection 250 MG

    Falsolieva 250 mg contains Fulvestrant, a hormonal anticancer medicine classified as a Selective Estrogen Receptor Degrader (SERD). It works by binding to estrogen receptors and causing their degradation, thereby blocking estrogen-driven growth of hormone-dependent breast cancer cells.

    View Details
    • 1

    24/7 Clients Support

    Best Price

    Quality Assurance